Kodiak Sciences Overview
Kodiak Sciences Target Price
Analysts' 12-month price predictions for KOD.
Get informed when a big investor buys or sells
+ FollowShare Price
$43.26
Average Target Price
$63.75
47.4% upside
47.4% upside4 analysts in the last 4 months
High: $80 | Low: $56
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-11 | Chardan Capital | $61 | 41% upside |  |
| 2026-03-27 | UBS | $80 | 84.9% upside | |
| 2026-03-27 | H.C. WainwrightMatthew Caufield | $58 | 34.1% upside | |
| 2026-03-26 | Jefferies | $56 | 29.4% upside | |
| 2026-01-22 | H.C. WainwrightMatthew Caufield | $38 |  12.2% downside | |
| 2026-01-07 | UBSMichael Yee | $50 | 15.6% upside | |
| 2025-09-25 | BarclaysGena Wang | $17 | 60.7% downside | |
| 2024-12-09 | JefferiesMichael Yee | $20 | 53.8% downside | |
| 2024-09-24 | Goldman SachsAndrea Tan | $2 | 95.4% downside | |
| 2022-11-14 | Morgan Stanley | $9 | 79.2% downside | |
| 2022-11-10 | Goldman Sachs | $8 | 81.5% downside | |
| 2022-08-15 | Morgan Stanley | $12 | 72.3% downside | |
| 2022-08-10 | Chardan Capital | $18 | 58.4% downside | |
| 2022-08-09 | Truist Financial | $15 | 65.3% downside | |
| 2022-08-09 | Goldman Sachs | $9 | 79.2% downside | |
| 2022-05-24 | Goldman Sachs | $5 | 88.4% downside | |
| 2022-05-11 | Goldman Sachs | $7 | 83.8% downside | |
| 2022-02-11 | Goldman SachsAndrea Tan | $70 | 61.8% upside | |
| 2021-11-12 | BMO CapitalMatthew Luchini | $114 | 163.5% upside | |